Comparison Lineage Cell Therapeutics (LCTX) with Competitors
Lineage Cell Therapeutics (LCTX) industry is Biotechnology.
Operating Margin
LCTX-440.20%
Industry-2055.25%
Upside+1615.05%
Free Cash Flow Yield
LCTX-7.40%
Industry-1.75%
Upside-5.65%
P/E
LCTX-4.40
Industry-20.52
Upside+1611.88%
Forward P/E
LCTX30.67
Industry16.33
Upside+87.81%
P/S
LCTX20.58
Industry10.01
Upside+105.52%
P/B
LCTX5.65
Industry5.15
Upside+9.78%